• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Insufficient Information (3190)
Patient Problems Stroke/CVA (1770); Embolism/Embolus (4438)
Event Date 06/13/2022
Event Type  Death  
Event Description
A patient underwent an aortic valve replacement with a perceval m valve on (b)(6) 2022 due to aortic valve stenosis.A concomitant cabg x3 was performed, left atrial appendage occlusion, and partial ablation of the left atrium for atrial fibrillation.The procedure was completed uneventfully, and the patient was transferred to the icu in hemodynamically stable conditions.The patient had signs and symptoms of stroke post-surgery ((b)(6) 2022).Ct head nad.Was planned for follow up mri.The patient had some thickened fluids.The patient apparently had a distended abdo.A ct abdo was planned.On way to ct, the patient vomited, aspirated, arrested, and couldn¿t be revived.The patient unfortunately died on (b)(6) 2022.The patient was therapeutically warfarinised at time of stroke.Background history includes obesity, hypertension, type ii diabetes mellitus, increased cholesterol, atrial fibrillation.Other medical history includes prostate cancer and lung cancer.
 
Manufacturer Narrative
Unknown device disposition.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.The manufacturer attempted to retrieve additional information on this event.However, no further information has been provided to date, despite the manufacturer's attempts.Based on the information available, it is not possible to establish a definitive root cause of the reported event.However, from the document review performed, no manufacturing deficiencies were identified.It is possible that patient clinical, history and risk factors (i.E.Obesity, hypertension, increased cholesterol, atrial fibrillation) has contributed to the reported event but since the device was not returned to the manufacturer for further investigation, this cannot be ultimately confirmed.Should any further information be received in the future, the manufacturer will submit a follow up report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
roberta lamberti
5005 north fraser way
burnaby, bc 
MDR Report Key14981812
MDR Text Key295671598
Report Number3004478276-2022-00167
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)240929
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS23
Device Catalogue NumberICV1209
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/14/2022
Initial Date FDA Received07/11/2022
Supplement Dates Manufacturer Received07/14/2022
Supplement Dates FDA Received08/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Death;
Patient Age73 YR
Patient SexMale
-
-